Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 56 (representing 30 labs)

Tests names and labsConditionsGenes and analytesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

FH. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

FH. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Renal Cancer Sequencing Panel

PreventionGenetics
United States
2619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Mutations in the fumarate hydratase gene

Service de Génétique Gustave Roussy
France
11
  • E Enzyme assay
  • I Immunohistochemistry
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
845637
  • D Deletion/duplication analysis

Hereditary Leiomyomatosis and Renal Cell Cancer or Fumarase Deficiency via the FH Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

LEIOMYOMATOSIS AND RENAL CELL CANCER

Laboratorio de Genetica Clinica SL
Spain
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

VistaSeq Renal Cell Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
1919
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Leiomyomatosis, Deletions-Duplications (MLPA) FH Gene

Reference Laboratory Genetics
Spain
11
  • D Deletion/duplication analysis

Leiomyomatosis, Sequencing FH Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Hereditary Renal Cancer Panel

Blueprint Genetics
Finland
425
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Renal / Urinary Cancer Comprehensive Panel

Fulgent Genetics
United States
77327
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Paraganglioma-Pheochromocytoma Comprehensive Panel

Fulgent Genetics
United States
37111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Sarcoma Comprehensive Panel

Fulgent Genetics
United States
92026
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Cancer Panel

Fulgent Genetics
United States
1735124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pancreatic Cancer Comprehensive Panel

Fulgent Genetics
United States
61322
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Epilepsy NGS Panel

Fulgent Genetics
United States
3052447
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ONCOLOGY, PANEL

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
6780
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 56

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center